Lactose India appoints Alpesh A. Lakeshri as cost auditor for FY27
- Lactose (India) Limited appointed Alpesh A. Lakeshri as Cost Auditor for FY27
- Shareholders approved the appointment on September 30, 2026
- Lakeshri qualified as CMA in June 2022 and started practice in August 2023
- He previously worked with Kirit Mehta & Company for four and a half years
*this image is generated using AI for illustrative purposes only.
Lactose (India) Limited has appointed Alpesh A. Lakeshri as its Cost Auditor for the financial year ending March 31, 2027. The appointment was approved by shareholders during their meeting held on September 30, 2026.
The move complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed BSE Limited that the appointment was made upon the recommendation of the Board of Directors.
Auditor Profile and Experience
Alpesh A. Lakeshri qualified as a Cost and Management Accountant (CMA) in June 2022 and commenced his own practice in August 2023. Prior to establishing his firm, he spent nearly four and a half years with Kirit Mehta & Company – Cost Accountants, where he supervised multiple cost audit teams.
His expertise includes the preparation of cost records and adherence to regulations under Section 148 of the Indian Companies Act, 2013. He currently serves as a Cost Auditor for several entities, including:
- Piramal Pharma Limited
- Jenburkt Pharmaceuticals Limited
- SeQuent Scientific Limited
- Jgsonpal Pharmaceuticals Limited
- Megafine Pharma (P) Limited
- Alivira Healthcare Private Limited
- Gangwal Healthcare Private Limited
- Innovation Imaging Technologies Private Limited
- Innvolution Healthcare Private Limited
- J. Kumar – NCC Private Limited
- Shakti Auto Industries Private Limited
Compliance Details
| Particulars | Details |
|---|---|
| Reason for Change | Appointment of Cost Auditors for FY27 |
| Date of Appointment | September 30, 2026 |
| Term | Financial year ending March 31, 2027 |
| Relationship Disclosure | NA |
The company confirmed there are no relationships between the director and the newly appointed auditor.
Historical Stock Returns for Lactose
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.54% | -4.53% | +0.38% | +31.14% | -16.18% | +161.01% |
How might Alpesh A. Lakeshri's concurrent role as Cost Auditor for Piramal Pharma and other major pharmaceutical firms influence Lactose India's cost optimization strategies?
What impact could the new cost audit framework have on Lactose India's production efficiency and profit margins for the FY27 period?
Does the appointment signal a broader strategic shift in Lactose India's governance standards or preparation for potential regulatory changes in the dairy sector?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
